ACP: AI Recommendations More Often Better Quality for Virtual Care Visits
By Elana Gotkine HealthDay Reporter
MONDAY, April 7, 2025 -- Artificial intelligence (AI) recommendations are more often rated as better quality than final recommendations of physicians for virtual care visits made by patients with respiratory, urinary, vaginal, eye, or dental symptoms, according to study published online April 4 in the Annals of Internal Medicine to coincide with the Internal Medicine Meeting, the annual meeting of the American College of Physicians, held from April 3 to 5 in New Orleans.
In a retrospective cohort study, Dan Zeltzer, Ph.D., from Tel Aviv University in Israel, and colleagues conducted a retrospective cohort study to compare initial AI recommendations with final recommendations of physicians who had access to the AI recommendations and may or may not have reviewed them. Data were collected from a virtual primary and urgent care clinic. Data were included for 461 physician-managed visits for adults with respiratory, urinary, vaginal, eye, or dental symptoms from June 12 to July 14, 2024, with AI recommendations of sufficient confidence and complete medical records.
The researchers found that for 56.8 percent of the visits, initial AI and final physician recommendations were concordant. AI recommendations were more often rated as optimal compared with treating physician decisions (77.1 versus 67.1 percent). Quality scores were equal, better for AI, and better for treating physicians in 67.9, 20.8, and 11.3 percent of cases, respectively.
"AI can enhance clinical decision-making for common acute symptoms in a virtual urgent care setting," the authors write. "Thoughtful integration of AI into clinical practice, combining its strengths with those of physicians, could improve the quality of care."
The study was funded by K Health.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-08 06:00
Read more

- Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor VVD-159642 for Treatment of Advanced Solid Tumors
- Unnecessary Imaging Scans Contributing To Climate Change
- 2009 to 2019 Saw Increase in Avoidable Mortality in United States
- Parents Feel They Are Lacking Information About Bird Flu
- FDA Issues Complete Response Letter for Etripamil for PSVT
- Depression, Anxiety Common Among Chronic Pain Patients
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions